Rezai Arwin, Pöppe Johannes P, Spendel Mathias, Kraus Theo F J, Stevanovic Vlado, Griessenauer Christoph J, Schwartz Christoph
Department of Neurological Surgery, University Hospital Salzburg, Salzburg, AUT.
Department of Pathology, University Hospital Salzburg, Salzburg, AUT.
Cureus. 2023 Feb 17;15(2):e35111. doi: 10.7759/cureus.35111. eCollection 2023 Feb.
We report an 81-year-old patient who underwent microsurgical resection of a posterior fossa mass lesion. Intraoperative findings were suggestive of the presence of two distinctly different tumor types within the lesion, one of which was well-circumscribed and avascular, whereas the other one showed an adhesive growth pattern and extensive vascularisation. Histopathological analysis, including deoxyribonucleic acid (DNA)-methylation-based classification, substantiated the intraoperative impression and confirmed the presence of a subependymoma central nervous system (CNS) World Health Organization (WHO) grade 1 as well as the presence of a hemangioblastoma CNS WHO grade 1. To our knowledge, our patient represents only the second reported case of such a rare constellation. Even though DNA-methylation-based classification is not yet required for the classification of all CNS tumor types by the 2021 WHO classification of tumors of the CNS, it proved to be crucial to verify the final diagnosis in our patient. In the future, DNA-methylation analysis will most likely become an important asset in neuro-oncological diagnostics and further help to guide treatment strategies in complex or rare clinical cases.
我们报告了一名81岁的患者,该患者接受了后颅窝肿块病变的显微手术切除。术中发现提示病变内存在两种明显不同的肿瘤类型,其中一种边界清晰且无血管,而另一种呈浸润性生长模式且血管丰富。组织病理学分析,包括基于脱氧核糖核酸(DNA)甲基化的分类,证实了术中的判断,并确认存在1级中枢神经系统(CNS)室管膜下瘤以及1级CNS血管母细胞瘤。据我们所知,我们的患者是第二例报道的这种罕见组合病例。尽管2021年WHO中枢神经系统肿瘤分类尚未要求对所有CNS肿瘤类型进行基于DNA甲基化的分类,但事实证明它对于我们患者的最终诊断至关重要。未来,DNA甲基化分析很可能会成为神经肿瘤诊断中的一项重要工具,并进一步有助于指导复杂或罕见临床病例的治疗策略。